Search PDMR transactions

Notifier
Name of person with notification obligation
Nils Anders Haegerstrand
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Nils Anders Haegerstrand
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Annexin Pharmaceuticals AB (publ)
Issuer´s LEI code
5493000JP703HGPJEX27
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Annexin Pharmaceuticals AB SE0009664154 Acquisition 145,600 Quantity 0.25 SEK 03/07/2024 Outside a trading venue
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Annexin Pharmaceuticals AB SE0009664154 Acquisition 03/07/2024 Outside a trading venue 145,600 (Quantity) 0.25 SEK
Total: 145,600
<< Back